Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0191120230380320248
Journal of Korean Medical Science
2023 Volume.38 No. 32 p.248 ~ p.248
COVID-19 Vaccination Status Among Korean Pediatric Population With Comorbidities
Shin A-Reum

Kim Dong-Wook
Kim Young-Eun
Kim Doo-Ri
Jung Jae-Hun
Kim Yae-Jean
Abstract
The pediatric population with comorbidities is a high-risk group for severe coronavirus disease 2019 (COVID-19). As of January 2023, the COVID-19 vaccination rate for at least two doses among Korean children 5?11 years is low at 1.1%. We summarized the COVID-19 vaccination status for the pediatric population (5?17 years) with comorbidities through July 2022 using the National Health Insurance Service database. Pediatric patients with comorbidities had higher vaccination rates than the general pediatric population (2.4% vs. 1.1% in 5?11-year-olds [P < 0.001], 76.5% vs. 66.1% in 12?17-year-olds [P < 0.001]). However, there were substantial differences according to comorbidity category, and the 2-dose vaccination rate was lowest among children with immunodeficiency in all age groups (1.1% in 5?11-year-olds, 51.2% in 12?17-year-olds). The COVID-19 vaccination rate among Korean children has remained stagnant at a low proportion despite ongoing outreach. Thus, more proactive strategies are needed alongside continuous surveillance.
KEYWORD
COVID-19 Vaccine, Children, Comorbidity
FullTexts / Linksout information
 
Listed journal information